Literature DB >> 3208450

Subclass distribution and IgE responses after treatment in human schistosomiasis.

B Evengård1, L Hammarström, C I Smith, S G Johansson, E Linder.   

Abstract

The IgG and IgA subclass distribution of specific antibodies as well as the distribution of total and specific IgE in 15 patients with schistosomiasis was determined in consecutive samples before and after initiation of treatment. An adult worm antigen preparation and a soluble egg antigen preparation were used as antigens in the ELISA assays. After initiation of treatment a rise was noted in certain subclasses and a correlation was found for specific IgG1 and IgG4 serum levels in the egg-excreting patients against adult worm antigen and for specific IgG4 and IgE levels in sera from the eight patients with a chronic disease. They also had a rise of the specific IgA1 titre and six of them also of specific IgA2. Members of eosinophilic granulocytes reached a peak after 2 weeks in seven of the eight patients. The increase of eosinophils was an early event as opposed to the incidence of peak of the determined specific isotypes. The associated rise in IgG1, IgG4 and IgE antibody concentrations and eosinophils may suggest a causal relation possibly induced by common interleukins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3208450      PMCID: PMC1541751     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities.

Authors:  F Lee; T Yokota; T Otsuka; P Meyerson; D Villaret; R Coffman; T Mosmann; D Rennick; N Roehm; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

2.  Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4.

Authors:  C J Sanderson; A O'Garra; D J Warren; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

Review 3.  Effector and regulatory mechanisms in immunity to schistosomes: a heuristic view.

Authors:  A Capron; J P Dessaint
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

4.  Enzyme-linked immunosorbent assay for subclass distribution of human IgG and IgA antigen-specific antibodies.

Authors:  M A Persson; L Hammarström; C I Smith
Journal:  J Immunol Methods       Date:  1985-04-08       Impact factor: 2.303

5.  Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections.

Authors:  V A Sundqvist; A Linde; B Wahren
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

6.  Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter.

Authors:  Y Noma; P Sideras; T Naito; S Bergstedt-Lindquist; C Azuma; E Severinson; T Tanabe; T Kinashi; F Matsuda; Y Yaoita
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

7.  IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors.

Authors:  L Hammarström; M Granström; V Oxelius; M A Persson; C I Smith
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

8.  Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3.

Authors:  C A Smith; D M Rennick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

9.  IgE responses in human filariasis. IV. Parallel antigen recognition by IgE and IgG4 subclass antibodies.

Authors:  R Hussain; E A Ottesen
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

10.  Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures.

Authors:  C J Sanderson; D J Warren; M Strath
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

View more
  5 in total

1.  IgG subclasses in human chronic schistosomiasis: over-production of schistosome-specific and non-specific IgG4.

Authors:  F N Boctor; J B Peter
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Early antibody responses in human schistosomiasis.

Authors:  B Evengård; L Hammarström; C I Smith; E Linder
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

3.  In vivo expression of human immunoglobulin germ-line mRNA in normal and in immunodeficient individuals.

Authors:  K B Islam; B Baskin; B Christensson; L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

4.  Effective anthelmintic therapy of residents living in endemic area of high prevalence for Hookworm and Schistosoma mansoni infections enhances the levels of allergy risk factor anti-Der p1 IgE.

Authors:  Sabrina S Campolina; Marcio S S Araujo; Tércia M R L Rezende; Leonardo Matoso; Humberto F O Quites; Andréa Teixeira-Carvalho; Olindo A Martins-Filho; Andrea Gazzinelli; Rodrigo Correa-Oliveira
Journal:  Results Immunol       Date:  2013-12-05

5.  Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.

Authors:  Kate M Mitchell; Francisca Mutapi; Takafira Mduluza; Nicholas Midzi; Nicholas J Savill; Mark E J Woolhouse
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.